Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 13, 2023

SELL
$39.13 - $47.24 $253,288 - $305,784
-6,473 Reduced 4.54%
136,130 $5.51 Million
Q4 2022

Feb 14, 2023

SELL
$41.91 - $50.48 $214,830 - $258,760
-5,126 Reduced 3.47%
142,603 $7.11 Million
Q3 2022

Nov 14, 2022

BUY
$40.9 - $50.42 $625,361 - $770,921
15,290 Added 11.54%
147,729 $6.1 Million
Q2 2022

Aug 12, 2022

BUY
$42.98 - $49.77 $787,780 - $912,234
18,329 Added 16.06%
132,439 $6.25 Million
Q4 2021

Feb 14, 2022

SELL
$50.62 - $56.47 $243,684 - $271,846
-4,814 Reduced 4.05%
114,110 $6.34 Million
Q2 2021

Aug 16, 2021

BUY
$46.28 - $52.75 $655,556 - $747,203
14,165 Added 13.52%
118,924 $5.75 Million
Q1 2021

May 14, 2021

SELL
$46.25 - $56.02 $811,780 - $983,263
-17,552 Reduced 14.35%
104,759 $5.1 Million
Q4 2020

Mar 01, 2021

BUY
$46.09 - $54.74 $2.36 Million - $2.81 Million
51,262 Added 72.15%
122,311 $6.46 Million
Q3 2020

Nov 13, 2020

SELL
$42.51 - $52.42 $4.73 Million - $5.83 Million
-111,251 Reduced 61.03%
71,049 $3.71 Million
Q2 2020

Aug 14, 2020

BUY
$39.49 - $44.36 $3.65 Million - $4.09 Million
92,312 Added 102.58%
182,300 $7.8 Million
Q1 2020

May 15, 2020

BUY
$33.17 - $41.6 $1.29 Million - $1.62 Million
38,902 Added 76.15%
89,988 $3.74 Million
Q3 2019

Nov 14, 2019

SELL
$32.73 - $40.81 $596,046 - $743,190
-18,211 Reduced 26.28%
51,086 $1.68 Million
Q2 2019

Aug 15, 2019

SELL
$35.73 - $41.39 $292,378 - $338,694
-8,183 Reduced 10.56%
69,297 $0
Q1 2019

May 14, 2019

BUY
$33.78 - $40.68 $501,835 - $604,342
14,856 Added 23.72%
77,480 $0
Q2 2018

Aug 14, 2018

SELL
$31.23 - $37.47 $162,427 - $194,881
-5,201 Reduced 7.67%
62,624 $0
Q1 2018

May 14, 2018

SELL
$31.01 - $34.72 $129,218 - $144,678
-4,167 Reduced 5.79%
67,825 $0
Q4 2017

Feb 09, 2018

SELL
$30.68 - $35.37 $73,724 - $84,994
-2,403 Reduced 3.23%
71,992 $0
Q3 2017

Nov 13, 2017

BUY
$31.02 - $32.94 $2.31 Million - $2.45 Million
74,395
74,395 $0

Others Institutions Holding QGEN

About QIAGEN N.V.


  • Ticker QGEN
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 227,694,000
  • Market Cap $10.4B
  • Description
  • QIAGEN N.V. offers sample to insight solutions that transform biological materials into molecular insights worldwide. The company provides primary sample technology consumables, such as nucleic stabilization and purification kits for primary sample materials, manual and automated processing for genotyping, gene expression, and viral and bacteria...
More about QGEN
Track This Portfolio

Track Ubs Asset Management Americas Inc Portfolio

Follow Ubs Asset Management Americas Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ubs Asset Management Americas Inc, based on Form 13F filings with the SEC.

News

Stay updated on Ubs Asset Management Americas Inc with notifications on news.